Health & Wellbeing

A new programme which has already helped well over 100 smokers in Wolverhampton to quit has been extended for another 12 months.

Midlands Air Ambulance Charity has celebrated the first six months of operations undertaken by its new Airbus H145 helicopter, at a special event held at Royal Stoke University Hospital in Stoke-on-Trent.

Decathlon is releasing its first-ever European survey on cycling habits among young people, offering new insights into how Gen Z moves through cities, and what's holding them back.

A warning has been issued over Dubai chocolate and similar products amid concerns for customer safety, particularly for people with allergies.

In the quiet corridors of Birmingham Community Healthcare (BCHC) hospitals, something profoundly human is unfolding — a comforting presence that meets people at the hardest moment of their lives.

Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, have announced the continued expansion of its commercial team in preparation for the anticipated U.S. launch of the LIBERTY System, which is projected during the third quarter of 2025.

In celebration of Autistic Pride Day this month, we’re highlighting the positive impact of ongoing SEND initiatives by British Fencing (BF) and our partners, promoting inclusivity in the sport and transforming lives.

As the month of May brought two key awareness events into focus, a Norfolk housebuilder donated a bundle of mental health-themed books to support pupils at Sprowston Junior School. 

A new multimillion-pound plan aims to guarantee a healthy working life to everyone in West Yorkshire, through new personalised support for people who are out of work because of a disability or health condition.

With millions suffering silently from chronic pain and complex conditions, The LDN Book 4: Case Studies in Chronic Pain (LDN Research Trust) is offering timely and life-changing insights into one of medicine's best-kept secrets — low dose naltrexone (LDN).

Publishing on June 6, 2025, and launching at the LDN 2025 Conference, this fourth instalment in the internationally renowned LDN Book series focuses on real-life case studies where patients have achieved remarkable improvements — and in some cases, complete transformations — through the use of LDN. From autoimmune diseases and hormonal imbalances to chronic pain syndromes like fibromyalgia, Ehlers-Danlos Syndrome, and inflammatory conditions, this new collection of case studies highlights LDN's growing potential as a non-toxic, low-cost, and accessible therapy.

Educator Kim Fields, who lives with chronic neurological pain, gave the book 5 stars on NetGalley: "Low-dose naltrexone is one of the best-kept secrets in the medical world.

 “This book aims to shed light on how life-changing LDN can be for myriad conditions. My hope is that books like this will prompt more scientific research for LDN."

Meanwhile, medical professionals are taking note. NetGalley Reviewer Amethyst Maxey shared: "It was very educational and will be a great tool to add in my practice."

With Pain Awareness Month coming up in September, alongside Invisible Disabilities Week and World Mental Health Day (10 October), The LDN Book 4 arrives at a time when there is growing demand for alternative and integrative options for patients who have been left behind by mainstream medicine. Editor Linda Elsegood, founder of the LDN Research Trust, who lives in Norfolk, says: "This book is for patients, carers, and practitioners. The stories within it are real.  

“They show what is possible with LDN — and why we urgently need more research, access, and education around this treatment."

NICEIC, the UK’s leading certification body for the electrical industry, is urging families to prioritise electrical safety in and around their homes this Child Safety Week 2025 (2–8 June).

Colleagues at Kent Community Health NHS Foundation Trust (KCHFT) can now add ‘national health heroes’ to their title, after scooping a digital innovation award for transforming how quickly new staff are recruited.

Paul Barnett, a 47-year-old from Birmingham donates plasma regularly in honour of his three-year-old granddaughter who made a full recovery after a Kawasaki disease diagnosis.

Qualifyze, already the global leader in third-party audit services for the pharmaceutical industry, announces the launch of Quality Insights Platform, an AI-powered platform that transforms the world's largest pharmaceutical audit database into a strategic risk management tool.

Zulal Wellness Resort by Chiva-Som, the Middle East’s first and largest full-immersion wellness resort and the world’s first contemporary showcase of Traditional Arabic and Islamic Medicine (TAIM), invites guests to discover a millennium of holistic wellbeing with its ‘Wellness Plus’ offer.*

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, have announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for mirdametinib, a MEK inhibitor, for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in paediatric and adult patients with neurofibromatosis type 1 (NF1) aged 2 years and above.